Clinical Trial Update: A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

View source ↗

Summary

A real-world clinical trial update assessing disease activity in adolescents and adults with atopic dermatitis treated with oral upadacitinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING